A detailed history of Jefferies Group LLC transactions in Deciphera Pharmaceuticals, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 175,148 shares of DCPH stock, worth $0. This represents 0.03% of its overall portfolio holdings.

Number of Shares
175,148
Previous 691,000 74.65%
Holding current value
$0
Previous $9.09 Million 64.34%
% of portfolio
0.03%
Previous 0.09%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$12.38 - $20.23 $6.39 Million - $10.4 Million
-515,852 Reduced 74.65%
175,148 $3.24 Million
Q3 2022

Nov 14, 2022

SELL
$12.38 - $20.23 $6.22 Million - $10.2 Million
-502,514 Reduced 72.72%
188,518 $3.24 Million
Q2 2022

Sep 21, 2023

SELL
$9.11 - $13.98 $1.59 Million - $2.45 Million
-175,000 Reduced 20.21%
691,000 $9.09 Million
Q2 2022

Aug 15, 2022

SELL
$9.11 - $13.98 $1.61 Million - $2.46 Million
-176,302 Reduced 20.33%
691,032 $9.09 Million
Q1 2022

Sep 21, 2023

BUY
$6.87 - $11.11 $5.86 Million - $9.48 Million
853,547 Added 6854.15%
866,000 $8.03 Million
Q1 2022

May 16, 2022

BUY
$6.87 - $11.11 $5.87 Million - $9.5 Million
854,881 Added 6864.86%
867,334 $8.03 Million
Q4 2021

Sep 21, 2023

BUY
$7.7 - $37.13 $31,993 - $154,275
4,155 Added 50.07%
12,453 $121,000
Q4 2021

Feb 14, 2022

BUY
$7.7 - $37.13 $31,993 - $154,275
4,155 Added 50.07%
12,453 $122,000
Q3 2021

Sep 21, 2023

SELL
$26.46 - $37.15 $1.02 Million - $1.44 Million
-38,660 Reduced 82.33%
8,298 $281,000
Q3 2021

Nov 15, 2021

SELL
$26.46 - $37.15 $1.02 Million - $1.44 Million
-38,660 Reduced 82.33%
8,298 $282,000
Q2 2021

Sep 21, 2023

BUY
$32.73 - $47.95 $953,457 - $1.4 Million
29,131 Added 163.41%
46,958 $1.72 Million
Q2 2021

Aug 16, 2021

BUY
$32.73 - $47.95 $953,457 - $1.4 Million
29,131 Added 163.41%
46,958 $1.72 Million
Q1 2021

Sep 21, 2023

SELL
$40.39 - $56.73 $6.89 Million - $9.68 Million
-170,691 Reduced 90.54%
17,827 $799,000
Q1 2021

May 14, 2021

BUY
$40.39 - $56.73 $455,478 - $639,744
11,277 Added 172.17%
17,827 $799,000
Q3 2020

Nov 13, 2020

SELL
$43.8 - $58.16 $462,265 - $613,820
-10,554 Reduced 61.7%
6,550 $336,000
Q2 2020

Aug 14, 2020

BUY
$37.05 - $65.03 $210,777 - $369,955
5,689 Added 49.84%
17,104 $1.02 Million
Q1 2020

May 15, 2020

SELL
$33.63 - $69.4 $154,193 - $318,199
-4,585 Reduced 28.66%
11,415 $470,000
Q4 2019

Feb 13, 2020

BUY
$31.7 - $69.93 $507,200 - $1.12 Million
16,000 New
16,000 $996,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.